US$ 26.22
does medicaid cover glp-1 drugs Coverage of and Spending on GLP-1s Medicaid Coverage of and Spending
Description
The Phase III trial of this pipeline drug for treating type 2 diabetes mellitus, non-alcoholic fatty liver disease, and obesity started on August 28, 2023

For external use only

Triple agonist (GLP-1/GIP/Glucagon), under clinical investigation

read about the other uses of glp1.

Partner with GenScript today to advance your GLP-1 based therapeutics.

Learn about GLP-1 receptor agonists (exenatide, liraglutide, semaglutide, tirzepatide) their mechanism, dosing, cautions, side effects, and interactions
